Scorpion Therapeutics Strikes Major $162m Funding Round For ‘Precision Oncology 2.0™’

Less than three months after breaking cover with an impressive $102 million series A, Scorpion has whipped up another major funding round, nabbing $162 million for its next-gen cancer drugs.